ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,488,749 | +122.3% | 2,929,818 | +129.2% | 0.00% | +50.0% |
| Q2 2023 | $4,717,240 | +2466.4% | 1,278,385 | +2202.1% | 0.00% | – |
| Q1 2023 | $183,807 | +85391.6% | 55,531 | 0.0% | 0.00% | – |
| Q4 2022 | $215 | -99.8% | 55,531 | -4.6% | 0.00% | – |
| Q3 2022 | $141,000 | +11.9% | 58,179 | -9.0% | 0.00% | – |
| Q2 2022 | $126,000 | +18.9% | 63,962 | +10.9% | 0.00% | – |
| Q1 2022 | $106,000 | +30.9% | 57,672 | 0.0% | 0.00% | – |
| Q4 2021 | $81,000 | -30.8% | 57,672 | -44.1% | 0.00% | – |
| Q3 2021 | $117,000 | -47.5% | 103,218 | -25.9% | 0.00% | – |
| Q2 2021 | $223,000 | -16.5% | 139,313 | -8.2% | 0.00% | – |
| Q1 2021 | $267,000 | +853.6% | 151,713 | +1181.4% | 0.00% | – |
| Q3 2020 | $28,000 | -48.1% | 11,840 | -16.2% | 0.00% | – |
| Q1 2019 | $54,000 | +58.8% | 14,127 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | – | 14,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |